
A one-year clinical trial involving 295 participants found that a tailored exercise program reduced the time spent in atrial fibrillation (AFib) by 45% compared to usual care.
The exercise group spent 3.9% of their time in AFib versus 7.1% for the control group, while also achieving a 37% reduction in total hospitalizations and 46% fewer AFib-related hospitalizations.
Presented at the European Society of Cardiology Congress 2026, the study utilized insertable cardiac monitors to track heart activity in patients with an average age of 64.